Related Experiment Videos
Intravenous KCl supplementation in pediatric cardiac surgical patients
Insights
This study found that intravenous potassium chloride (KCl) supplementation is safe and effective for pediatric cardiac surgery patients. Monitoring serum potassium levels is crucial due to variable patient responses to KCl infusions.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Clinical Pharmacology
Background:
- Postoperative hypokalemia is a concern in pediatric cardiac surgery patients.
- Accurate potassium (K) dosing is essential for managing electrolyte balance and preventing complications.
Purpose of the Study:
- To determine the dose-response characteristics of intravenous potassium chloride (KCl) supplementation in pediatric patients after cardiac surgery.
- To evaluate the safety and efficacy of a specific KCl infusion protocol.
Main Methods:
- Prospective study of 31 pediatric cardiac surgery patients.
- Intravenous KCl (0.5 meq/kg) infused over 2 hours as needed to maintain serum K ≥ 4.0 meq/liter.
- Serum K measured before and after KCl administration; 100 administrations evaluated.
Main Results:
- Mean K dose administered was 0.72 ± 0.23 meq/kg, resulting in a mean serum K rise of 0.61 ± 0.48 meq/liter.
- 11% of administrations showed no change or a decrease in serum K.
- 4% of administrations resulted in serum K > 5.0 meq/liter.
Conclusions:
- Intravenous KCl supplementation at 0.5 meq/kg over 2 hours is safe and effective in pediatric postoperative cardiac patients.
- Variable patient responses necessitate regular serum potassium monitoring to guide therapy.
- This dosing strategy helps manage hypokalemia in a vulnerable patient population.
Abstract:
A total of 31 pediatric cardiac patients (mean age 19 1/2 months) who required surgery for repair of various congenital heart defects were prospectively studied in the postoperative period to determine potassium (K) dose-response characteristics. All patients received supplementary K when the serum K was less than 4.0 meq/liter. A total of 100 administrations of intravenous potassium chloride (KCl) were evaluated. KCl, 0.5 meq/kg, was infused over 2 h by syringe pump. This infusion was repeated as necessary to achieve a serum K greater than or equal to 4.0 meq/liter. The KCl was administered in addition to the K in the patients' maintenance solution. Blood samples for serum K determination were collected 15-30 min before and after the KCl infusion. The mean K dose administered was 0.72 +/- 0.23 meq/kg. This produced a mean rise in serum K of 0.61 +/- 0.48 meq/liter. Of 100 administrations, 11 resulted in no change or a decrease in serum K. Four of 100 administrations resulted in serum K greater than 5.0 meq/liter. Intravenous KCl supplementation in a dose of 0.5 meq/kg administered over 2 h is safe and effective for pediatric postoperative cardiac patients. Serum K should be measured to monitor therapy, due to variable response.